Are biotechs underestimating regulatory groundwork
Bio matters
Related Posts
OGT launches enhanced genetic profiling panel for CLL
New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV V3 Panel, […]
NIHR and TJBCM announce new funding initiative for novel brain tumour research
The condition is the ninth most common cancer in the UK and affects 12,300 people annually The National Institute for Health and Care Research (NIHR) […]
NHS expands COVID-19 research platform for other major diseases
The OpenSAFELY platform will support the discovery of new treatments The NHS has announced the expansion of its COVID-19 research platform, OpenSAFELY, […]